" /> Pertuzumab/Trastuzumab/Paclitaxel Followed by FEC Regimen - CISMeF





Preferred Label : Pertuzumab/Trastuzumab/Paclitaxel Followed by FEC Regimen;

NCIt synonyms : Pertuzumab Trastuzumab Paclitaxel Followed by Fluorouracil/Epirubicin/Cyclophosphamide; Pertuzumab-Trastuzumab-Paclitaxel Followed by Fluorouracil-Epirubicin-Cyclophosphamide; Pertuzumab Trastuzumab Paclitaxel Followed by FEC; Pertuzumab/Trastuzumab/Paclitaxel Followed by Fluorouracil/Epirubicin/Cyclophosphamide;

NCIt definition : A regimen consisting of pertuzumab, trastuzumab and paclitaxel, followed by fluorouracil, epirubicin and intravenous cyclophosphamide, used as a neoadjuvant or adjuvant treatment for HER-2/neu-positive breast cancer.;

NCIt note : Source: NCCN Guidelines 2017;

NCI Metathesaurus CUI : CL524991;

Détails


Vous pouvez consulter :


Nous contacter.
29/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.